NCT06541210 Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
| NCT ID | NCT06541210 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Prostate Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-05-04 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2024-05-04 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial the possibility of establishing a Community Living Labs (CoLLab) Learning Health System to facilitate access to prostate health Risk, Education, and Assessment in the Community with Help (REACH) services in Black men and compares the impact to American Legion Posts with no CoLLab set up at the individual and community levels. Cancer is the second leading cause of death for Black men and Black men are less likely to receive prostate cancer screening. CoLLab Learning Health System utilizes community health workers (CHW) that are well-trained to form a bridge between communities and clinicians. In fact, Black men who work with CHW's typically have better access to health services, gain knowledge about cancer, cancer prevention, treatment and may have better overall health outcomes. Establishing a CoLLab Learning Health System at American Legion Posts may improve access to clinical trials and prostate cancer services in Black men.
Eligibility Criteria
Inclusion Criteria: * AIMS 1 AND 3: Participants must be one of the following key personnel: * Community PI (n=1), * CoLLab Program Manager (n=1) * CoLLab Site Managers (n=3) * CoLLab CAB members (n=21) * 2 Community Health Workers (CHWs) per Post site (n=6) * AIMS 1 AND 3: Between the ages of 21 and 80. * AIMS 1 AND 3: Able to complete the survey in English. * AIMS 1 AND 3: Reside in the Jacksonville, FL and/or surrounding counties. * AIMS 1 AND 3: Willing and able to consent to the study. * AIM 2: Black adult of any gender. * AIM 2: Must be between the ages of 30 and 80. * AIM 2: Able to speak English. * AIM 2: Reside in the Jacksonville, FL and/or surrounding counties. * AIM 2: Willing and able to consent to the study. Exclusion Criteria: * AIMS 1 AND 3: Younger than 21years or older than 80 years. * AIMS 1 AND 3: Not a resident of NE Florida. Unwilling or unable to consent to the study. * AIM 2: Younger than 30 years or older than 80 years. * AIM 2: Not a resident of NE Florida. * AIM 2: Unwilling or unable to consent to the study.
Contact & Investigator
Folakemi T. Odedina, Ph.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06541210 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 80 Years, studying Prostate Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06541210 currently recruiting?
Yes, NCT06541210 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT06541210 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT06541210 clinical trial?
NCT06541210 is sponsored by Mayo Clinic. The principal investigator is Folakemi T. Odedina, Ph.D. at Mayo Clinic. The trial plans to enroll 250 participants.